Skip to main content
. 2021 Aug 6;10(8):950. doi: 10.3390/antibiotics10080950

Figure 2.

Figure 2

Flow chart for the patient/sample selection process from the study. Patients diagnosed with a carbapenemase-producing Gram-negative bacterial BSI were sampled for testing with the T2Resistance™ panel. Microbiological tests on which the diagnosis was based are highlighted in gray. BCs, blood cultures; MALDI-TOF MS, matrix-assisted laser desorption ionization–time of flight mass spectrometry; BSIs, bloodstream infections.